In March of 2019, the study published by Yamada, et al. first reported that TSKU overexpression enhanced cell proliferation activity and inhibited the epithelial-mesenchymal transition (EMT) in lung cancer cell lines [17]. The gene discussed is TSKU; the disease is lung carcinoma.